ArTS Archivio della ricerca di Trieste

TEDESCO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.691
EU - Europa 18.131
AS - Asia 15.451
SA - Sud America 5.057
AF - Africa 628
OC - Oceania 403
Continente sconosciuto - Info sul continente non disponibili 19
Totale 66.380
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.483
CN - Cina 5.460
IT - Italia 4.744
BR - Brasile 2.987
DE - Germania 2.045
SG - Singapore 1.844
ES - Italia 1.576
GB - Regno Unito 1.310
MX - Messico 1.297
PL - Polonia 1.240
JP - Giappone 1.191
IN - India 1.082
FR - Francia 1.059
TR - Turchia 1.010
SE - Svezia 949
HK - Hong Kong 772
ID - Indonesia 771
UA - Ucraina 702
CA - Canada 682
VN - Vietnam 668
NL - Olanda 555
KR - Corea 533
RU - Federazione Russa 518
CO - Colombia 483
PT - Portogallo 472
AR - Argentina 463
TW - Taiwan 452
FI - Finlandia 443
PE - Perù 387
GR - Grecia 353
CL - Cile 345
AU - Australia 334
AT - Austria 268
TH - Thailandia 261
CH - Svizzera 253
BE - Belgio 237
EC - Ecuador 218
IE - Irlanda 206
RO - Romania 198
SA - Arabia Saudita 197
DK - Danimarca 167
PK - Pakistan 161
EG - Egitto 146
IR - Iran 141
BG - Bulgaria 137
CZ - Repubblica Ceca 118
IL - Israele 116
MY - Malesia 101
MA - Marocco 99
PH - Filippine 97
HU - Ungheria 91
ZA - Sudafrica 89
IQ - Iraq 78
HR - Croazia 75
SI - Slovenia 69
RS - Serbia 67
NZ - Nuova Zelanda 66
TN - Tunisia 61
VE - Venezuela 61
BD - Bangladesh 53
LB - Libano 53
LT - Lituania 53
PA - Panama 52
NO - Norvegia 50
LV - Lettonia 47
AE - Emirati Arabi Uniti 42
BO - Bolivia 39
CR - Costa Rica 38
JO - Giordania 38
KZ - Kazakistan 36
NG - Nigeria 36
UY - Uruguay 36
SK - Slovacchia (Repubblica Slovacca) 35
DZ - Algeria 34
GT - Guatemala 34
UZ - Uzbekistan 31
PY - Paraguay 30
NP - Nepal 27
QA - Qatar 27
LK - Sri Lanka 26
HN - Honduras 25
PS - Palestinian Territory 23
SY - Repubblica araba siriana 21
OM - Oman 20
SN - Senegal 20
BY - Bielorussia 19
GE - Georgia 19
CY - Cipro 18
KE - Kenya 17
DO - Repubblica Dominicana 16
EE - Estonia 16
ET - Etiopia 16
AZ - Azerbaigian 15
NI - Nicaragua 15
KW - Kuwait 12
BA - Bosnia-Erzegovina 11
LU - Lussemburgo 11
PR - Porto Rico 11
RE - Reunion 11
CD - Congo 10
Totale 66.131
Salva come PNG Salva come JPEG
Città #
Ashburn 9.148
Fairfield 1.260
Singapore 1.179
Woodbridge 1.179
Ann Arbor 1.039
Germantown 1.013
Houston 913
Warsaw 787
Chandler 636
Beijing 610
Milan 601
Jacksonville 592
Wilmington 570
Seattle 566
Rome 539
San Jose 518
São Paulo 509
Hong Kong 477
Dallas 476
Munich 468
Cambridge 434
Trieste 422
Madrid 406
Shanghai 362
Guangzhou 341
Tokyo 323
Istanbul 304
Los Angeles 298
Seoul 282
Chicago 274
Hefei 264
Rio de Janeiro 250
Lima 249
Barcelona 247
Paris 239
New York 229
Princeton 229
Ho Chi Minh City 222
Frankfurt am Main 214
Bogotá 210
Hangzhou 203
Hanoi 192
Athens 185
Buenos Aires 184
Dublin 184
Helsinki 184
Taipei 181
Santiago 180
Boardman 176
Jakarta 171
Lisbon 169
Izmir 168
Moscow 167
Vienna 157
Ankara 156
Montréal 151
Naples 149
Chengdu 146
Mcallen 143
Bangkok 139
Turin 139
Columbus 136
Bologna 135
Bengaluru 133
The Dalles 129
Amsterdam 127
Florence 126
London 123
Sofia 121
Curitiba 115
Nanjing 115
Brasília 110
Berlin 106
Mumbai 104
Medellín 103
Chennai 102
Hyderabad 102
Toronto 102
Melbourne 100
Zurich 100
Washington 98
Buffalo 97
Valencia 97
Las Vegas 96
Zgierz 96
Lauterbourg 94
Wuhan 93
San Diego 92
Quito 91
Montreal 90
Sydney 90
Belo Horizonte 89
Guadalajara 89
Porto Alegre 89
Copenhagen 88
Thessaloniki 88
Brussels 87
Verona 87
Benito Juarez 86
Porto 86
Totale 36.415
Salva come PNG Salva come JPEG
Nome #
Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice. 44.736
Pathogenic role of complement in antiphospholipid syndrome and therapeutic implications 770
Targeted delivery of neutralizing anti-C5 antibody to renal endothelium prevents complement- dependent tissue damage 405
Complement Protein C1q binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumour Growth 396
A non-complement-fixing antibody to  2 glycoprotein I as a novel therapy for antiphospholipid syndrome 337
Targeting CD34+ cells of the inflamed synovial endothelium by guided nanoparticles for the treatment of rheumatoid arthritis 337
C1q as a novel player in angiogenesis with therapeutic implication in wound healing 334
New insight into antiphospholipid syndrome: antibodies to β2glycoprotein I-domain 5 fail to induce thrombi in rats 319
Selective therapeutic control of C5a and the terminal complement complex by anti-C5 single-chain Fv in an experimental model of antigen-induced arthritis in rats. 311
Complement as a biological tool to control tumor growth 307
C1q is involved in human trophoblast invasion 297
C1q secreted in the tumour microenvironment promotes tumour growth in the absence of complement activation 288
Pre-eclampsia is associated with defective production of C1q by invasive trophoblast 283
C1q is associated with a reduced inflammatory response of decidual endothelial cells 281
Targeted nanoparticles and complement activation 278
Innate immunity, through late complement components activation, contributes to the development of early vascular inflammation and morphologic alterations in experimental diabetes. 268
An update on the xenograft and mouse models suitable for investigating new therapeutic compounds for the treatment of B-cell malignancies. 261
C1q: A novel angiogenic factor? 254
Critical role and therapeutic control of the lectin pathway of complement activation in an abortion-prone mouse mating 251
Complement component C1q as potential diagnostic but not predictive marker of preeclampsia 250
Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo. 247
Chemerin Regulates NK Cell Accumulation and Endothelial Cell Morphogenesis in the Decidua during Early Pregnancy 242
Placental trophoblast and endothelial cells as target of maternal immune response. 236
Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59 226
An insight into normal and pathological pregnancies using large-scale microarrays: lessons from microarrays. 226
Complement as effector system in cancer immunotherapy. 224
Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5 223
In vivo targeting of human neutralizing antibodies against CD55 and CD59 to lymphoma cells increases the antitumor activity of rituximab. 218
Complement C1q and C8beta deficiency in an individual with recurrent bacterial meningitis and adult-onset systemic lupus erythematosus-like illness. 218
Complement activated by chimeric anti-folate receptor antibodies is an efficient effector system to control ovarian carcinoma. 216
Bilirubin inhibits the TNFα-related induction of three endothelial adhesion molecules 213
The seventh complement component is expressed on endothelial cells membrane and exerts an anti-inflammatory action 208
Bactericidal activities of human polymorphonuclear leukocyte proteins against Escherichia coli 0111:B4 coated with C5 or C8 200
Preeclampsia is associated with defective production of C1q by invasive trophoblast 200
CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival. 199
Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo 195
The terminal complement complex induces vascular leakage: in vitro and in vivo evidence 192
Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5. 191
MBL interferes with endovascular trophoblast invasion in pre-eclampsia. 191
OP0023 Targeted Polymeric Nanoparticles as Diagnostic and Therapeutic Tool for Rheumatoid Arthritis 191
The neutrophil-activating protein of Helicobacter pylori crosses endothelia to promote neutrophil adhesion in vivo. 190
Complement in human diseases: Lessons from complement deficiencies. 186
Inherited complement deficiencies and bacterial infections. 185
Dynamics of complement activation in aHUS and how to monitor eculizumab therapy 185
Bilirubin inhibits the TNFalpha-related induction of three endothelial adhesion molecules. 181
Mannose binding lectin and C3 act as recognition molecules for infectious agents in the vagina 179
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor. 178
Exploratory study on the effects of biodegradable nanoparticles with drugs on malignant B cells and on a human/mouse model of Burkitt lymphoma. 173
Platelet-activating factor and kinin-dependent vascular leakage as a novel functional activity of the soluble terminal complement complex. 172
The Complement System at the Embryo Implantation Site: Friend or Foe? 172
Chacterization of soluble terminal complement complex assembled in C8ß-deficient plasma and serum 167
The soluble terminal complement complex (SC5b-9) up-regulates osteoprotegerin expression and release by endothelial cells: implications in rheumatoid arthritis. 165
Analysis of the molecular mechanisms of C1-inhibitor deficiency induced angioedema 164
FRI0030 Anti-TNF-α Antibody Targeted To Inflamed Synovial Tissue for The Treatment of Rheumatoid Arthritis 163
Biological response of B lymphoma cells to anti-CD20 monoclonal antibody Rituximab in vitro: CD55 and CD59 regulate complement mediated lysis. 162
Complement activation in animal and human pregnancies as a model for immunological recognition 161
P-selectin glycoprotein ligand-1 as a potential target for humoral immunotherapy of multiple myeloma. 161
Cross-talk between the complement and the kinin system in vascular permeability 161
Selection and characterization of a novel agonistic human recombinant anti-TRAIL-R2 minibody with anti-leukemic activity. 159
null 159
Serum-Resistant Strains of Borrelia burgdorferi Evade Complement-Mediated Killing by Expressing a CD59-Like Complement Inhibitory Molecule 158
Posttransplant ischemia-reperfusion injury in transplanted heart is prevented by a minibody to the fifth component of complement. 158
Humoral immunotherapy of multiple myeloma: perspectives and perplexities. 156
The C7 component of the complement system localizes to vascular smooth muscle cells and endothelium in human first trimester decidua 156
Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency. 155
null 155
C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function. 155
null 154
VE-cadherin is a critical molecule for trophoblast-endothelial cell interaction in decidual spiral arteries. 153
null 151
Hepatocyte nuclear factor 1a controls the expression of terminal complement genes 149
Role of the B1 Bradykinin Receptor and gC1qR/p33 in Angioedema 149
The cleavage site of C5 from man and animals as a common target for neutralizing human monoclonal antibodies: in vitro and in vivo studies 148
C1q induces in vivo angiogenesis and promotes wound healing 148
In vivo biodistribution and lifetime analysis of cy5.5-conjugated rituximab in mice bearing lymphoid tumor xenograft using time-domain near-infrared optical imaging. 147
Fluvastatin treatment inhibits leucocyte adhesion and extravasation in models of complement-mediated acute inflammation. 146
The development of atypical hemolytic uremic syndrome depends on complement C5. 146
Cross-talk between the complement system and endothelial cells in physiologic conditions and in vascular diseases. 145
Mast cells are critically involved in serum-mediated vascular leakage in chronic urticaria beyond high-affinity IgE receptor stimulation 142
Feto-maternal immune interaction at the placental level 141
An elctrophysiological study of the effects of myasthenia gravis sera and complement on rat isolated muscle fibres. 140
The membrane attack complex of complement induces caspase activation and apoptosis. 140
Protection against inflammation- and antiphospholipid antibody-caused fetal loss by the chemokine decoy receptor D6 140
The endothelium is an extrahepatic site of synthesis of the seventh component of the complement system. 135
Pathophysiological consequences of complement-endothelial cell interaction 134
Complement-endothelial cell interaction: pathophysiological implications. 132
Experimental induction of myelin changes by anti-MAG antibodies and terminal complement complex 132
An alternative role of C1q in cell migration and tissue remodeling: contribution to trophoblast invasion and placental development. 131
INTRACEREBROVENTRICULAR INJECTION OF THE TERMINAL COMPLEMENT COMPLEX CAUSES INFLAMMATORY REACTION IN THE RAT BRAIN 128
Inflammatory response and the endothelium 127
Endothelial cell E- and P-selectin and vascular cell adhesion molecule-1 function as signaling receptors. 127
Complement production by trophoblast cells at the feto-maternal interface. 124
Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. 122
null 121
null 121
null 121
null 119
null 110
null 109
Decidual endothelial cells express surface-bound C1q as a molecular bridge between endovascular trophoblast and decidual endothelium. 109
Totale 64.176
Salva come PNG Salva come JPEG
Categoria #
all - tutte 104.961
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.961
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021470 0 0 0 0 0 0 0 0 0 200 79 191
2021/20221.322 57 77 73 121 40 132 62 43 146 156 90 325
2022/20231.865 185 248 147 274 147 362 6 158 235 7 71 25
2023/20241.016 65 56 64 33 154 137 153 177 19 15 83 60
2024/202520.730 29 34 138 171 209 245 283 197 358 219 5.897 12.950
2025/202631.270 5.645 4.908 5.655 5.179 5.092 2.351 888 186 735 631 0 0
Totale 66.685